For the Inventor, By the Inventor

Enter assignee name

La Jolla, CA, United States of America

Sibia Neurosciences, Inc.

USPTO Granted Patents = 48

Forward Citations = 634

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Steven B Ellis (18 out of 40 patents)

Michael Miller Harpold (18 out of 46 patents)

Ian A McDonald (12 out of 57 patents)

4. Mark E Williams (10 out of 24 patents)

5. Robert Brenner (9 out of 13 patents)

6. Nicholas David Cosford (9 out of 16 patents)

7. Elisabeth Albrecht (8 out of 14 patents)

8. Benito Munoz (8 out of 9 patents)

9. Ann F McCue (6 out of 11 patents)

10. Jeffrey Paul Whitten (6 out of 68 patents)

11. Daniel H Feldman (5 out of 8 patents)

12. Lorrie P Daggett (5 out of 17 patents)

13. Jean-Michel Andre Vernier (5 out of 56 patents)

14. Gonul Velicelebi (4 out of 29 patents)

15. Paul Brust (4 out of 14 patents)

Core Competencies:

Neurodegenerative Disorders

Protease Inhibitors

Calcium Channels

Nicotinic Acetylcholine Receptors

Metabotropic Glutamate Receptors

Automated Assays

Peptide Analogues

Cation-Based Bioassays

Nucleic Acids Encoding

Human Receptor Compositions

Pichia Proteolytic Activity

Modulators of Acetylcholine Receptors

48 patents: Sort by Forward Citations

1. 6153171 - Methods for identifying compounds effective for treating (2000-11-28),

2. 6127133 - Automated analysis equipment and assay method for detecting cell surface (2000-10-03),

3. 6096514 - Human calcium channel compositions and methods (2000-08-01),

4. 6057114 - Automated assays and methods for detecting and modulating cell surface (2000-05-02),

5. 6051684 - Methods of treating neurodegenerative disorders using protease inhibitors (2000-04-18),

6. 6051419 - Genes which influence pichia proteolytic activity, and uses therefor (2000-04-18),

7. 6033865 - Human n-methyl-d-aspartate receptor type 1 subunits, DNA encoding same (2000-03-07),

8. 6022704 - DNA and mRNA encoding an .alpha..sub.4 subunit of human neuronal (2000-02-08),

9. 6017887 - Peptide, peptide analog and amino acid analog protease inhibitors (2000-01-25),

10. 6015879 - Peptide and peptide analog protease inhibitors (2000-01-18),

11. 6013474 - Calcium channel compositions and methods (2000-01-11),

12. 6001581 - Cation-based bioassay using human metabotropic glutamate receptors (1999-12-14),

13. 5985586 - Methods for identifying compounds that modulate the activity of human (1999-11-16),

14. 5981193 - Human neuronal nicotinic acetylcholine receptor compositions and methods (1999-11-09),

15. 5969100 - Peptide, peptide analog and amino acid analog protease inhibitors (1999-10-19),

Sibia Neurosciences, Inc. is a leading biopharmaceutical company focused on developing innovative therapies for neurological disorders. With extensive research in neurology and a highly dedicated team, we strive to improve patients' lives by addressing significant unmet medical needs. Our cutting-edge treatments are developed through rigorous scientific processes and stringent quality standards. Visit our website to learn more about our groundbreaking advancements in neurosciences.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

48 Patents

#15 in La Jolla, CA

#1,667 in California

#7,012 in US

#14,122 in the World

La Jolla, CA, United States of America

Sibia Neurosciences, Inc.

Forward Citations = 634

34 inventors:

Steven B Ellis (18 out of 40 patents)

Michael Miller Harpold (18 out of 46 patents)

Ian A McDonald (12 out of 57 patents)

4. Mark E Williams (10 out of 24 patents)

5. Robert Brenner (9 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…